October 3, 2011

AMGEN INC: Neutroval(M) Patent Litigation with Teva Settled

COMPANIES: Amgen Inc
Subscribe

Patent litigation between Teva and Amgen Inc. relating to Neutroval(TM) (a recombinant form of human G-CSF) has been settled, Amgen disclosed in its August 8, 2011, Form 10-Q filing with…

TO CONTINUE READING,LOGIN or
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | United States